PM Parker

1.6k total citations
21 papers, 1.2k citations indexed

About

PM Parker is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, PM Parker has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in PM Parker's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (7 papers). PM Parker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (7 papers). PM Parker collaborates with scholars based in United States and Germany. PM Parker's co-authors include GM Schmidt, DS Snyder, EP Smith, MR O’Donnell, AP Nademanee, A. Molina, DE Stepan, Auayporn Nademanee, AS Stein and SJ Forman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

PM Parker

18 papers receiving 1.1k citations

Peers

Countries citing papers authored by PM Parker

Since Specialization

Citations

This map shows the geographic impact of PM Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PM Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PM Parker more than expected).

Fields of papers citing papers by PM Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PM Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PM Parker. The network helps show where PM Parker may publish in the future.

Co-authorship network of co-authors of PM Parker

This figure shows the co-authorship network connecting the top 25 collaborators of PM Parker. A scholar is included among the top collaborators of PM Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PM Parker. PM Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia 2010 ·Bone Marrow Transplantation ·Anthony S. Stein, Margaret O’Donnell, Timothy W. Synold, Andrew Dagis, (unknown), Auayporn Nademanee, PM Parker, Vinod Pullarkat, David S. Snyder, Ricardo Spielberger, (unknown), Joseph Alvarnas, Sandra H. Thomas, Stephen J. Forman	3
2	Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (RI-HCT) For MDS Using Tacrolimus/Sirolimus As GVHD Prophylaxis 2010 ·Biology of Blood and Marrow Transplantation ·Ryotaro Nakamura, Joycelynne Palmer, Joseph Chao, Tracey Stiller, Vinod Pullarkat, PM Parker, Anthony S. Stein, David S. Snyder, (unknown), Ravi Bhatia, Karen Chang, (unknown), David Senitzer, Stephen J. Forman, Margaret O’Donnell	0
3	A Phase II Study of Sequential Velcade/Thalidomide/ Dexamethasone (VTD) as Maintenance Therapy Post Single Autologous Peripheral Stem Cell (PSCT) in Patients with Multiple Myeloma. 2009 ·Blood ·Firoozeh Sahebi, Amrita Krishnan, George Somlo, Leslie Popplewell, PM Parker, (unknown), Len Farol, Ricardo Spielberger, Neil Kogut, Chatchada Karanes, Christopher Ruel, Paul Frankel, (unknown), (unknown), Margaret O’Donnell, Stephen J. Forman	0
4	Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16). 2008 ·Blood ·Margaret O’Donnell, PM Parker, Andrew Dagis, ML Slovak, D. Snyder, Anthony S. Stein, Ricardo Spielberger, Anna Pawłowska, Joseph Rosenthal, Joycelynne Palmer, Neil Kogut, Stephen J. Forman	0
5	Phase I trial of escalating doses of total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan and PBPC as part of tandem high-dose therapy (THDT) for patients with multiple myeloma (MM) 2007 ·Journal of Clinical Oncology ·Jeffrey Y.C. Wong, George Somlo, Ricardo Spielberger, Stephen J. Forman, (unknown), Timothy E. Schultheiss, Paul Frankel, A. Krishnan, Firoozeh Sahebi, PM Parker	1
6	High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission 2000 ·Leukemia ·AS Stein, MR O’Donnell, (unknown), AP Nademanee, Andrew Dagis, GM Schmidt, PM Parker, DS Snyder, EP Smith, George Somlo, Kim Margolin, Daniel A. Arber, Joyce C. Niland, SJ Forman	14
7	Donor leukocyte infusions in acute lymphocytic leukemia 2000 ·Bone Marrow Transplantation ·(unknown), Steven C. Goldstein, Sergio Giralt, John E. Levine, David Porter, William R. Drobyski, John Barrett, Mark D. Johnson, Allan D. Kirk, Mary M. Horowitz, PM Parker	177
8	Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission 1999 ·Leukemia ·DS Snyder, (unknown), MR O’Donnell, PM Parker, AS Stein, Kim Margolin, George Somlo, A Molina, Ricardo Spielberger, A. Kashyap, Henry C. Fung, ML Slovak, Andrew Dagis, RS Negrin, (unknown), KG Blume, SJ Forman	81
9	Thalidomide as salvage therapy for chronic graft-versus-host disease 1995 ·Blood ·PM Parker, Nelson J. Chao, AP Nademanee, MR O’Donnell, GM Schmidt, DS Snyder, (unknown), EP Smith, A. Molina, DE Stepan	140
10	The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone 1995 ·Blood ·Auayporn Nademanee, GM Schmidt, PM Parker, (unknown), (unknown), DS Snyder, M O’Donnell, EP Smith, DE Stepan, A. Molina	118
11	High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors 1995 ·Blood ·Auayporn Nademanee, MR O’Donnell, DS Snyder, GM Schmidt, PM Parker, AS Stein, EP Smith, A. Molina, DE Stepan, George Somlo	126
12	Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. 1994 ·Journal of Clinical Oncology ·Margaret O’Donnell, G. Schmidt, Bernard Tegtmeier, (unknown), J. L. Fahey, James I. Ito, AP Nademanee, Joyce C. Niland, PM Parker, EP Smith	131
13	High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. 1994 ·Journal of Clinical Oncology ·Auayporn Nademanee, Irena Sniecinski, GM Schmidt, Andrew Dagis, Margaret O’Donnell, DS Snyder, PM Parker, Anthony S. Stein, EP Smith, A Molina	105
14	Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase 1994 ·Blood ·DS Snyder, RS Negrin, MR O’Donnell, NJ Chao, (unknown), GD Long, AP Nademanee, AS Stein, PM Parker, EP Smith	31
15	Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase 1994 ·Blood ·DS Snyder, RS Negrin, MR O’Donnell, (unknown), (unknown), GD Long, (unknown), AS Stein, PM Parker, EP Smith	1
16	Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. 1991 ·Journal of Clinical Oncology ·N J Chao, (unknown), GD Long, GM Schmidt, Timothy A. Donlon, PM Parker, ML Slovak, (unknown), KG Blume, Stephen J. Forman	47
17	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission 1991 ·Blood ·NJ Chao, SJ Forman, GM Schmidt, (unknown), MD Amylon, (unknown), AP Nademanee, MR O’Donnell, PM Parker, (unknown)	6
18	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission 1991 ·Blood ·NJ Chao, SJ Forman, GM Schmidt, (unknown), MD Amylon, (unknown), AP Nademanee, MR O’Donnell, PM Parker, (unknown)	94
19	Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia 1987 ·Blood ·SJ Forman, MR O’Donnell, AP Nademanee, DS Snyder, PJ Bierman, GM Schmidt, JL Fahey, AS Stein, PM Parker, KG Blume	6
20	Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia 1987 ·Blood ·SJ Forman, MR O’Donnell, AP Nademanee, DS Snyder, PJ Bierman, GM Schmidt, JL Fahey, AS Stein, PM Parker, KG Blume	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact